Snehjeev Ventures increases holding in Amerise Biosciences Ltd, surpassing 7% threshold
SNEHJEEV VENTURES PVT.LTD., along with associated Persons Acting in Concert (PAC), has increased its stake in Amerise Biosciences Ltd, crossing the seven percent holding mark. The acquisition of equity shares was completed through the open market on June 4, 2026.The acquiring group comprises SNEHJEEV VENTURES PVT.LTD., and the Persons Acting in Concert include RUSHANK SS LUNKAD, SNEHA LUNKAD, and RIDDHI LUNKAD. The acquirer entity is not affiliated with a Promoter or Promoter group of Amerise Biosciences Ltd.
The acquisition details show that before the transaction, the combined holding of SNEHJEEV VENTURES PVT.LTD. and its PACs stood at 4,618,896 shares, representing 6.99% of the total voting capital in the company. Amerise Biosciences Ltd is listed on BSE Limited.
The acquisition transaction involved the purchase of equity shares via the open market. As a result of the acquisition, the combined holding increased to 4,650,896 shares, bringing the stake up to 7.04% of the total voting capital.
A summary of the acquisition details is presented below:
| Metric | Before Acquisition | After Acquisition |
|---|---|---|
| Total Shares Held (Acquirer + PAC) | 4,618,896 | 4,650,896 |
| Percentage of Voting Capital | 6.99% | 7.04% |
| Mode of Acquisition | Open Market | Open Market |
The total equity share capital of Amerise Biosciences Ltd before the acquisition was Rs. 6,60,69,000, comprising 66,06,900 Equity Shares of Rs. 10/- each. Following the transaction, the entity maintained the same equity share capital and total voting capital structure.
Stock Price Movement
Amerise Biosciences Ltd settled at ₹0.74 today, closing with zero change on the stock. The shares traded completely flat throughout the day, as both the high and low remained locked at that exact price point.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.